Use of thrombectomy to retrieve larger thrombi improved neurological recovery at discharge in patients with acute ischemic stroke, according to a substudy of the MR CLEAN trial.
Deterioration of renal function, and an increase in related adverse events, may not be unusual in patients with nonvalvular atrial fibrillation prescribed nonvitamin K antagonist oral anticoagulants, according to recent study results in Heart and Vessels.
Cardiology Today has compiled coverage of major anticoagulation research recently published in journals, offering clinicians an overview of where the field stands in the use and effects of various therapies to manage CVD.
Published data from the HARMONY trial confirm a previous report that moderate-dose ranolazine plus reduced-dose dronedarone was well-tolerated and reduced atrial fibrillation burden, according to a report in Circulation: Arrhythmia & Electrophysiology.
Higher free thyroxine levels within the normal range increased the risk for atrial fibrillation, especially among younger adults, according to recent study findings published in The Journal of Clinical Endocrinology & Metabolism.
Oral edoxaban showed superior to subcutaneous enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty, according to findings published in Thrombosis Journal.
Trimethylamine-N-oxide, an organic compound produced by intestinal bacteria, was associated with coronary atherosclerosis burden and mortality among patients with chronic kidney disease in a recent study.
Данный сайт и вся информация на нём предназначена для медицинских работников.
Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.